Clinical Practice
Popular
- NEW EPISODEMinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
0.50 program credits
Aditya Bardia, MD, MPH, FASCO
Roberto Leon-Ferre, MD
Amy Comander, MD
Roberto Leon-Ferre, MD
Shelina Ramnarine, PhD
Terri DeNeui, DNP, APRN, ACNP-BC
- Project Oncology®
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
Jennifer Caudle, DO, FACOFP
Alexis Ann LeVee, MD
Jennifer Caudle, DO, FACOFP
Neil M. Iyengar, MD
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Monica Christmas, MD
Mary Jane Minkin, MD
Alexandria May, PharmD, BCPS
Mitchell D. Creinin, MD
Ryan Quigley
- On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
- On the Frontlines of Metastatic Breast Cancer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
- Clinician's Roundtable
New Insights into VKD: Exploring Maternal Obesity and Neonatal Vitamin K Status
